MD5

MD5 is a selective TMPRSS6 mimetic peptide inhibitor with an IC50 for recombinant human TMPRSS6 protein of 22 nM and a Ki of 3.4 nM. MD5 exhibits the significantly reduced inhibitory effect on Matriptase, with an IC50 of 352 nM and a Ki of 99.2 nM. MD5 exhibits good target specificity and only has a weak inhibitory effect on thrombin (Thrombin), with Ki of 120 nM. MD5 demonstrates good initial drugability and can be used for the study of iron overload diseases (such as hereditary hemochromatosis, β-thalassemia) [1].

Product Specifications

CAS Number

[3051556-89-6]

UNSPSC

12352209

Target

Ser/Thr Protease; Thrombin

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Smiles

O=C([C@@H](NC([C@@H](NC([C@@H](NC(CCC1=CC=CC=C1)=O)CC2=CSC=N2)=O)C3CCCCC3)=O)CCCNC(N)=N)C4=NC5=C(S4)C=CC=C5

Molecular Formula

C36H44N8O4S2

Molecular Weight

716.92

References & Citations

[1]Desgagné M, et al. Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket. J Med Chem. 2024 Aug 8;67 (15) :12969-12983.